Business Wire (Apr 2, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
624 people get RNN articles and Market Currents by email alert.
Get email alerts on RNN »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (Mar 11, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Jan 22, 2013)
-
Business Wire (Dec 4, 2012)
-
Business Wire (Nov 29, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 21, 2012)
-
Business Wire (Sep 26, 2012)
-
Business Wire (Sep 6, 2012)
-
Business Wire (Sep 4, 2012)
-
Business Wire (Aug 30, 2012)
-
Business Wire (Aug 6, 2012)
-
Business Wire (May 30, 2012)
To learn more about Seeking Alpha Pro, click here.
-
Inhibitex: This Is One You Might Want To Grow WithJohn Mylant • Wed, Nov 9, 2011
-
7 Stocks With CEO Buys of at Least $96,000 in the Past WeekThe Keating Letter • Thu, Apr 7, 2011
There are no Transcripts on RNN.
-
Business Wire (Mar 11, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Jan 22, 2013)
-
Business Wire (Dec 4, 2012)
-
Business Wire (Nov 29, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 28, 2012)
-
Business Wire (Nov 21, 2012)
-
Business Wire (Sep 26, 2012)
-
Business Wire (Sep 6, 2012)
-
Business Wire (Sep 4, 2012)
-
Business Wire (Aug 30, 2012)
-
at Fox Business (Aug 29, 2012)
-
Business Wire (Aug 6, 2012)
-
Business Wire (May 30, 2012)
-
Business Wire (May 8, 2012)
RNN vs. ETF Alternatives
Company Description
Currently, there's no company description for RNN.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, January 30, 11:13 AM Rexahn Pharmaceuticals (RNN +3.3%) moves up this morning after being initiated by analysts at Maxim with a Buy and a price target of $1.50 a share. The company specializes in oncology and CNS therapeutics, and has recently expanded its intellectual property around isoquinolinamine, a class of potent anti-cancer compounds, which provide potent anti-tumor activities in several human cancer cell lines, such as breast, prostate, colon, ovary, kidney, pancreas, glioblastoma and melanoma. Comment! [Healthcare, On the Move]
- Tuesday, January 22, 11:48 AM Rexahn Pharmaceuticals (RNN +4.9%) trades higher today after saying it's appointed Dr. Peter D. Suzdak as its new chief executive officer. Dr. Suzdak succeeds Dr. Chang Ahn, who was recently appointed as the company's chief scientist. Dr. Ahn will also remain as chairman of the company's board of directors. Comment! [Healthcare, On the Move]
- Wednesday, November 28, 2012, 4:47 PM Rexahn Pharmaceuticals (RNN) says it intends to offer shares of its common stock and warrants in an underwritten public offering. The shares are being offered as units, with no amount given at present. Earlier today the company announced it would be receiving additional funding from Teva Pharmaceutical (TEVA) for the development of its potential tumor treatment RX-3117. Burrill and Maxim Group are acting as joint book-running mangers for the offering. Comment! [Healthcare]
- Wednesday, November 28, 2012, 12:53 PM Rexahn Pharmaceuticals (RNN +9%) trades higher after the company said that Teva Pharmaceutical (TEVA -0.6%) will provide an additional $750K in funding to the company. Pursuant to the terms of an earlier agreementl, TEVA will purchase RNN's common stock at 120% of its closing price on the last trading day preceding the closing. TEVA has also agreed to commit additional research funding for development of RX-3117, a potential treatment for solid tumors including colon, lung and pancreatic cancers, and will retain the right to file the Investigational New Drug application with the FDA. 2 Comments [Healthcare, On the Move]
- Friday, July 6, 2012, 1:15 PM Off-radar microcap Rexahn Pharmaceuticals (RNN) is up another +16.6% today, having doubled since Monday's announcement that it's submitted an IND application to the FDA for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors. 4 Comments [Healthcare, On the Move]
-
Tuesday, February 8, 2011, 9:00 AM
Premarket gainers: RHB +46%. KND +26%. CNXT +17%. XIDE +15%. SOMX +6%. CXZ +5%. CPST +5%. MT +5%. BYD +4%. MGM +4%. NTWK +4%. MOTR +4%. CCME +4%.
Losers: BR -12%. GLUU -7%. OLP -6%. TEVA -5%. RNN -5%. BBEP -5%. PPNT -5%. AVP -4%. KTOS -4%. Comment! -
Thursday, December 2, 2010, 9:00 AM
Premarket gainers: WBD +30%. RNN +22%. PSS +16%. ANF +8%. WTSLA +8%. S +8%. FNSR +6%. SGMO +5%. STP +4%.
Losers: SQNM -9%. ARO -9%. SEP -4%. AEO -4%. Comment! -
Tuesday, October 19, 2010, 9:15 AM
Premarket gainers: CTIC +14%. MEE +10%. PH +9%. RNN +7%.
Losers: INFN -33%. CWTR -29%. OGXI -15%. KCI -13%. BXC -11%. HT -7%. BKCC -7%. NVO -7%. VMW -7%. AIB -6%. ABK -5%. RIO -5%. ALU -5%. AAPL -5%. HL -4%. IBM -4%. RCL -4%. AUY -4%. ARMH -4%. WFT -4%. BHP -4%. SLW -4%. TOT -4%. Comment! -
Thursday, September 2, 2010, 9:00 AM
Premarket gainers: OREX +27%. BKC +21%. CRME +12%. RNN +12%. CERS +8%. CTIC +5%. WEN +4%. MPEL +4%.
Losers: PSS -6%. Comment! -
Wednesday, June 23, 2010, 9:05 AM
Premarket gainers: JBL +11%. KMX +10%. RAD +10%. RNN +7%. SAY +5%. CTIC +4%. LYG +4%. ACAS +4%. VG +4%.
Losers: RGLD -5%. Comment! -
Thursday, May 13, 2010, 9:00 AM
Premarket gainers: SY +15%. PUDA +15%. TGB +10%. NNA +9%. WFMI +6%. DVAX +6%. RNN +5%. IMMU +4%. EBAY +4%. CLNE +4%.
Losers: RAS -9%. RPT -8%. AGEN -5%. VNR -5%. IRE -4%. WES -4%. Comment! -
Wednesday, April 28, 2010, 9:10 AM
Premarket gainers: NBG +10%. TSFG +8%. CIIC +7%. NVAX +8%. BCRX +7%. RFMD +6%. TLAB +6%. ACAS +6%. RNN +6%. YRCW +5%. ABK +5%. PCBC +5%. MPEL +5%. ERIC +5%. UAUA +4%. LCC +4%. DCTH +4%. TMO +4%. CRBC +4%. CMCSA +4%. GT +4%. CHU +4%. SQNM +4%.
Losers: BWLD -19%. RHI -11%. CNXT -10%. FBC -10%. PFCB -4%. 1 Comment -
Monday, April 19, 2010, 9:00 AM
Premarket gainers: CRN +35%. YMI +9%. CTIC +5%. IMMU +4%. SQNM +4%.
Losers: RNN -13%. TSFG -7%. SPF -7%. PALM -6%. FRE -5%. FNM -5%. Comment! -
Thursday, April 15, 2010, 9:00 AM
Premarket gainers: ME +38%. ANDS +25%. AEZS +20%. IDIX +16%. TSFG +15%. IOC +9%. PPHM +10%. ABK +8%. CPBY +8%. IMGN +8%. RNN +7%. SIRI +6%. XOM +6%. JOEZ +6%. END +5%. YRCW +5%. AVNR +5%. UPS +4%. MDVN +4%. SOLR +4%. SGY +4%.
Losers: SNTS -34%. TITN -13%. NEP -9%. SMOD -6%. REVU -6%. MAC -6%. MGM -6%. AGEN -4%. APA -4%. BPOP -4%. Comment! -
Wednesday, April 14, 2010, 9:00 AM
Premarket gainers: KLIC +21%. ABK +19%. CRXX +17%. RNN +9%. HOTT +8%. SIRI +7%. PAL +6%. AIB +6%. TLAB +5%. FNM +6%. INTC +4%. AMD +4%. ERIC +4%. MBI +4%. VVUS +4%. PALM +4%.
Losers: NBG -4%. Comment! -
Monday, April 12, 2010, 9:20 AM
Premarket gainers: DCP +48%. WEL +26%. DBTK +15%. ABK +15%. RNN +14%. MIR +163%. RRI +13%. PALM +8%. FCEL +7%. KERX +6%. AVNR +6%. ICOC +6%. CPKI +5%. JUEZ +5%. CIEN +5%. DYN +4%. UBS +4%.
Losers: CLNE -7%. Comment!
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.









